Purchase Order 75F40125P00188
Award Date
8/21/25
Potential Completion Date
11/19/25
Potential Value
$50K
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Herndon, VA 20191, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $38,503.16, was issued by the Food and Drug Administration (FDA) to Government Scientific Source Inc., a for-profit organization and leading distributor of laboratory products and equipment serving federal agencies. The contract is for the provision of PacBio Revio sequencing supplies, a critical tool for scientific research and testing. The contract was awarded under the Multiple Award Schedule (MAS) contract vehicle, indicating it is part of a larger,...
This is a $46,512 firm-fixed price purchase order awarded by the U.S. Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc., a small business manufacturer, for the delivery of reagents and consumables compatible with the FDA's PacBio Revio DNA/RNA sequencing instrument. The award is the result of a small business set-aside solicitation for these specialized sequencing supplies to support the FDA National Center for Toxicological Research's (NCTR) error-corrected...
The U.S. Food and Drug Administration awarded a Firm Fixed Price Purchase Order contract to Pacific Biosciences of California, Inc., a small business manufacturer, for the delivery of PacBio Revio sequencing reagent kits or equal products. The $48,715.20 contract has a completion date of September 30, 2024 and will support research at the FDA's National Center for Toxicological Research. This award is associated with a larger $1 million single-award Indefinite Delivery Indefinite Quantity (IDIQ)...
This is a firm-fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc., a small business manufacturer of genomic sequencing instruments and consumables. The contract is for the delivery of reagents and consumables for the FDA's PacBio Revio sequencing instrument system. The award has a ceiling value of $40,473.60 and a period of performance through September 30, 2025. This award was issued under a total small business...
This contract award is for the purchase of reagents and supplies from Pacific Biosciences of California, Inc. by the U.S. Department of Health and Human Services' Food and Drug Administration. The items include PacBio's proprietary single molecule real-time (SMRT) sequencing consumables such as template prep kits, binding kits, and SMRT cells to support the agency's genomic research initiatives. The $46,548 firm-fixed price delivery order does not utilize a set-aside program. Pacific Biosciences...
The Department of Health and Human Services Food and Drug Administration awarded a $61,236 firm fixed price delivery order contract to Pacific Biosciences of California, Inc. for the purchase of reagents and supplies including AMPure PB, barcoded overhang adapter kits, Sequel binding and internal control kit, Sequel pipet tips V2, Sequel sequencing kit, Sequel SMRT cell oil, SMRT Cell 1M V3 tray, and SMRTbell Express template prep. Performance will take place in Silver Spring, Maryland through...
The Food and Drug Administration (FDA) awarded a $1,000,000 firm-fixed price contract to Pacific Biosciences of California, Inc. for a PacBio Revio System. The Revio System will be used by the FDA's National Center for Toxicological Research to support its genetic and molecular toxicology research programs, particularly in the areas of mutation detection and sequencing. The contract has a period of performance through December 9, 2028 and includes a one-year warranty as well as four one-year...
This federal contract award is for the procurement of PacBio Sequel II and IIe system reagents and consumables by the Food and Drug Administration (FDA). The $15,713.10 firm-fixed price contract was awarded on July 23, 2024 to Pacific Biosciences of California, Inc., a leading manufacturer of high-throughput, long-read DNA sequencing platforms and associated products. The contract does not have a set-aside designation. Pacific Biosciences holds two relevant Indefinite Delivery Indefinite...
This firm-fixed-price purchase order was awarded to Pacific Biosciences of California, Inc. (PacBio), a leading manufacturer of high-throughput DNA sequencing systems and related consumables, by the U.S. Food and Drug Administration (FDA). The $48,715.20 contract is for the delivery of PacBio's Revio Reagent Kit, part number 102-817-900, with a period of performance through September 9, 2024. PacBio holds two significant IDIQ contract vehicles with federal agencies - a $13.5 million IDIQ with...
The Department of Health and Human Services Food and Drug Administration awarded a $51,193.93 purchase order to Pacific Biosciences of California, Inc. for sequencing supplies. The firm fixed price contract runs from August 23, 2023 to February 19, 2024 and will be performed by Pacific Biosciences in West Menlo Park, California. The original solicitation sought sequencing supplies as described in Combined Synopsis Solicitation 75F40123Q-117934 to support the FDA's evaluation of new sequencing...